{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:45:25Z","timestamp":1792421125735,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Pre-diabetes is an intermediate state between normal glucose metabolism and diabetes. Recent studies suggest that the presence of pre-diabetes is associated with poor outcomes after AIS. However, the results have been controversial. This study examines whether pre-diabetes influences the patients\u2019 short and long-term outcomes for AIS using IV thrombolysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 661 AIS patients with IV thrombolysis. Based on the 2010 ADA guidelines, patients were classified as pre-diabetes, with HbA1c levels of 5.7\u20136.4%; diabetes, with HbA1c levels more than 6.5%; and NGM (normal glucose metabolism), with HbA1c levels less than 5.7%. We investigated short-term outcomes, including early neurologic deterioration (END), in-hospital death, and poor functional outcomes (mRS\u2009&gt;\u20092) at 90\u2009days. As for long-term outcomes, poor functional outcomes were measured at 1\u2009year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 661 AIS patients treated with IV thrombolysis, 197 patients (29.8%) were diagnosed with pre-diabetes, and 210 (31.8%) were diagnosed with diabetes. In a multivariate analysis, pre-diabetes was an independent predictor for END (OR\u2009=\u20092.02; 95% CI 1.12\u20133.62;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.02) and in-hospital death (OR\u2009=\u20093.12; 95% CI 1.06\u20139.09;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.04). On the other hand, diabetes was a significant independent factor for poor long-term outcomes (OR\u2009=\u20091.75; 95% CI 1.09\u20132.78;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.02) after correcting confounding factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Unlike diabetes, pre-diabetes can be an important predictor of short-term outcomes after AIS. However, a more detailed research is needed to specify the precise mechanisms through which pre-diabetes affects the prognosis of acute ischemic stroke.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02102-1","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T15:42:10Z","timestamp":1613230930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pre-diabetes is a predictor of short-term poor outcomes after acute ischemic stroke using IV thrombolysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Byoung-Gwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kwan","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"2102_CR1","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"The Emerging Risk Factors Collaboration","year":"2010","unstructured":"The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215\u201322.","journal-title":"Lancet."},{"key":"2102_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/dmrr.490","volume":"20","author":"BN Mankovsky","year":"2004","unstructured":"Mankovsky BN. Ziegler D 2004. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004;20:268\u201387.","journal-title":"Diabetes Metab Res Rev"},{"key":"2102_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5853\/jos.2015.17.1.38","volume":"17","author":"BJ Kim","year":"2015","unstructured":"Kim BJ, Park J-M, Kang KS, Lee SJ, Ko YC, Kim JG, et al. Case characteristics, hyperacute treatment, and outcome information from the clinical research Center for Stroke-Fifth Division Registry in South Korea. J Stroke. 2015;17:38\u201353.","journal-title":"J Stroke"},{"key":"2102_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/STROKEAHA.111.000813","volume":"44","author":"J-P Desilles","year":"2013","unstructured":"Desilles J-P, Meseguer E, Labreusche J, Labreche J, Lapergue B, Sirimarco G, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systemic reviews. Stroke. 2013;44:1915\u201323.","journal-title":"Stroke."},{"key":"2102_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.STR.0000057975.15221.40","volume":"34","author":"S-E Megherbi","year":"2003","unstructured":"Megherbi S-E, Milan C, Minier D, Couvreir G, Osseby G-V Tilling K, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED stroke project. Stroke. 2003;34:688\u201394.","journal-title":"Stroke."},{"key":"2102_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000360810","volume":"37","author":"S Fonville","year":"2014","unstructured":"Fonville S, Zandbergen AAM, Koudstaal PJ, den Hertog HM. Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management. Cerebrovasc Dis. 2014;37:393\u2013400.","journal-title":"Cerebrovasc Dis"},{"key":"2102_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/NDT.S128807","volume":"13","author":"MD Mijajlovi\u0107","year":"2017","unstructured":"Mijajlovi\u0107 MD, Aleksi\u0107 VM, \u0160terni\u0107 NM, Mirkovic MM, Bornstein NM. Role of prediabetes in stroke. Neuropsychiatr Dis Treat. 2017;13:259\u201367.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2102_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.11.008","volume":"28","author":"Y Pan","year":"2019","unstructured":"Pan Y, Chen W, Wang Y. Prediabetes and outcomes of ischemic stroke or transient ischemic attack: a systemic review and meta-analysis. J Stroke Cerebrovasc Dis. 2019;28:683\u201392.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2102_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.005","volume":"27","author":"JP Marto","year":"2018","unstructured":"Marto JP, Saraiva M, Ladeira F, Sa F, Calado S, Viana-Baptista M. Prediabetes is associated with unfavorable outcome in young adult patients with ischemic stroke. J Stroke Cerebrovasc Dis. 2018;27:352\u20136.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2102_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jocn.2014.08.030","volume":"22","author":"C Lei","year":"2015","unstructured":"Lei C, Wu B, Liu M, Chen Y. Association between hemoglobin A1C levels and clinical outcome in ischemic stroke patients with or without diabetes. J Clin Neurosci. 2015;22:498\u2013503.","journal-title":"J Clin Neurosci"},{"key":"2102_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2013.06.010","volume":"332","author":"R Tanaka","year":"2013","unstructured":"Tanaka R, Ueno Y, Miyamoto N, Yamashiro K, Tanaka Y, Shimura H, Hattori N, et al. Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke. J Clin Neurol Sci. 2013;332:45\u201350.","journal-title":"J Clin Neurol Sci"},{"key":"2102_CR12","doi-asserted-by":"publisher","first-page":"e000957","DOI":"10.1136\/bmjdrc-2019-000957","volume":"8","author":"P Forti","year":"2020","unstructured":"Forti P, Maioli F, Nativio F, Maestri L, Coveri M, Zoli M. Association of pre-stroke glycemic status with stroke mortality. BMJ Open Diabetes Res Care. 2020;8:e000957.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2102_CR13","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1161\/STROKEAHA.117.018045","volume":"48","author":"HK Park","year":"2017","unstructured":"Park HK, Kim BJ, Han MK, Park JM, Kang KS, Lee SJ, et al. CRCS-K investigators. One-year outcomes after minor stroke or high-risk transient ischemic attack: Korean multicenter stroke registry analysis. Stroke. 2017;48:2991\u20138.","journal-title":"Stroke."},{"key":"2102_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5853\/jos.2014.16.3.161","volume":"16","author":"Y Ko","year":"2014","unstructured":"Ko Y, Lee S, Chung JW, Han MK, Park JM, Kang K, et al. MRI-based algorithm for acute ischemic stroke subtype classification. Stroke. 2014;16:161\u201372.","journal-title":"Stroke."},{"key":"2102_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35\u201341.","journal-title":"Stroke."},{"key":"2102_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.020","volume":"24","author":"SW Sohn","year":"2015","unstructured":"Sohn SW, Park HS, Cha JK, Nah HW, Kim DH, Kang MJ, et al. A systemized stroke code significantly reduced time intervals for using intravenous tissue plasminogen activator under magnetic resonance imaging screening. J Stroke Cerebrovasc Dis. 2015;24:465\u201372.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2102_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bmj.314.7090.1303","volume":"314","author":"CJ Weir","year":"1997","unstructured":"Weir CJ, Murrary GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303\u20136.","journal-title":"BMJ."},{"key":"2102_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jns.2012.04.018","volume":"319","author":"KH Choi","year":"2012","unstructured":"Choi KH, Park MS, Kim JT, Chang J, Nam TS, Choi SM, et al. Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke. J Neurol Sci. 2012;319:111\u20136.","journal-title":"J Neurol Sci"},{"key":"2102_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/STROKEAHA.114.006739","volume":"46","author":"F Irie","year":"2015","unstructured":"Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, Ago T, et al. Sex differences in short-term outcomes after acute ischemic stroke, The Fukuoka Stroke Registry. Stroke. 2015;46:471\u20136.","journal-title":"Stroke"},{"key":"2102_CR20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1161\/STROKEAHA.111.647610","volume":"43","author":"D Tanne","year":"2012","unstructured":"Tanne D, Koton S, Molshazki N, Goldbourt U, Shohat T, Tsabari R, et al. Trends in management and outcome of hospitalized patients with acute stroke and transient ischemic attack the National Acute Stroke Israeli (NASIS) registry. Stroke. 2012;43:2136\u201341.","journal-title":"Stroke."},{"key":"2102_CR21","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.017","volume":"27","author":"YN Mapoure","year":"2018","unstructured":"Mapoure YN, Ba H, Ayeah CM, Kenmegne C, Luma HN, Njamnshi AK. Acute stroke patients with newly diagnosed diabetes mellitus have poorer outcomes than those with previously diagnosed diabetes mellitus. J Stroke Cerebrovasc Dis. 2018;27:2327\u201335.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2102_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12883-017-0865-7","volume":"17","author":"S-J Lee","year":"2017","unstructured":"Lee S-J, Hong JM, Lee SE, Kang DR, Ovbiagele B, Demchuk AM, et al. Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes. BMC Neurol. 2017;17:101.","journal-title":"BMC Neurol"},{"key":"2102_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1212\/01.WNL.0000123252.55688.05","volume":"62","author":"T Karapanayiotides","year":"2004","unstructured":"Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Deuvyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62:1558\u201362.","journal-title":"Neurology."},{"key":"2102_CR24","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/STROKEAHA.108.517441","volume":"39","author":"M Kamalesh","year":"2008","unstructured":"Kamalesh M, Shen J, Eckert GJ. Long term postischemic stroke mortality in diabetes: a veteran cohort analysis. Stroke. 2008;39:2727\u201331.","journal-title":"Stroke."},{"key":"2102_CR25","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1161\/STROKEAHA.111.619049","volume":"42","author":"KK Anderson","year":"2011","unstructured":"Anderson KK, Anderson ZJ, Olsen TS. Predictors of early and late case-fatality in national wide Danish study of 26818 patients with first-ever ischemic stroke. Stroke. 2011;42:2806\u20133812.","journal-title":"Stroke."},{"key":"2102_CR26","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/STROKEAHA.114.005018","volume":"45","author":"S Palacio","year":"2014","unstructured":"Palacio S, McClure LA, Benavente OR, Bazan C 3rd, Pergoloa P, Hart RG. Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study. Stroke. 2014;45:2689\u201394.","journal-title":"Stroke."},{"key":"2102_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1474-4422(12)70005-4","volume":"11","author":"MJA Luitse","year":"2012","unstructured":"Luitse MJA, Biessels GJ, Rutten GEHM, Kapelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11:261\u201371.","journal-title":"Lancet Neurol"},{"key":"2102_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-510X(01)00566-4","volume":"189","author":"A Szczudlik","year":"2001","unstructured":"Szczudlik A, Slowik A, Turaj W, Wyrwicz-Petkow U, Pera J, Dziedzic T, et al. Transient hyperglycemia in ischemic stroke patients. J Neurol Sci. 2001;189:105\u201311.","journal-title":"J Neurol Sci"},{"key":"2102_CR29","doi-asserted-by":"publisher","first-page":"3B","DOI":"10.1016\/j.amjcard.2011.03.013","volume":"108","author":"RA DeFronzo","year":"2011","unstructured":"DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol. 2011;108:3B\u201324B.","journal-title":"Am J Cardiol"},{"key":"2102_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000319196","volume":"64","author":"A Ozkul","year":"2010","unstructured":"Ozkul A, Turgut ET, Akyol A, Yenisey C, Kadikoylu G, Tataroglu C, et al. The relationship between insulin resistance and hypercoagulability in acute ischemic stroke. Eur Neurol. 2010;64:201\u20136.","journal-title":"Eur Neurol"},{"key":"2102_CR31","doi-asserted-by":"publisher","first-page":"e2178","DOI":"10.1212\/WNL.0000000000010603","volume":"95","author":"TH Park","year":"2020","unstructured":"Park TH, Lee J-K, Park M-S, Park S-S, Hong K-S, Ryu W-S, et al. Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack. Neurology. 2020;95:e2178\u201391.","journal-title":"Neurology."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02102-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T15:44:31Z","timestamp":1613231071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02102-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-115467\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board of Dong-A University Hospital approved a request to waive of informed consent because it is not practicable to obtain consent from large numbers of patients for a retrospective chart review study, generally it also will not be appropriate to attempt to contact those patients to tell them about the study retrospectively. This study was approved by the Institutional Review Board of Dong-A University Hospital (DAUHIRB-17-149).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}